Ambamustine Hydrochloride

N/A

Report date: 2022/03/23 14:31:33
NME

Base Information

Drug NameAmbamustine Hydrochloride
Drug Alias Nameambamustinum氨莫司汀盐酸盐氨莫司汀ambamustineambamustina +[6] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsSmall Cell Lung CarcinomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesProter Laboratory Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A